PRP Hair Consent Form Requirements and Risk Disclosures
What information must an informed consent form for PRP hair restoration actually contain?
A signature at the bottom of a page doesn't prove that anyone understood anything. What makes a consent form hold up is whether it records that this particular patient grasped this particular procedure and chose it with the alternatives sitting in front of them. Everything else in the document exists to serve that one job.
- Procedure in plain words: Blood draw, centrifuge spin, then a grid of shallow scalp injections.
- Off-label position: Device clearance for preparing the plasma isn't approval for treating hair loss.
- Named risks: Specific complications listed individually, plus the plain chance of no improvement.
- Alternatives and money: Doing nothing, drug and device options, package pricing, refunds, maintenance.
A valid PRP hair restoration consent form names the procedure in plain language, states the off label regulatory position, lists specific expected and serious risks by name, presents alternatives including no treatment, documents that results are not guaranteed, separates financial and photography consent, and closes with a screening attestation and dated signature blocks.
What legal elements must informed consent cover for the document to be valid?
Consent is a conversation, and the form is only the receipt for it. Nobody asks whether you signed; they ask whether you were told the nature of the procedure, its material risks, its real benefits, the alternatives including walking away, and that you could withdraw at any point without your ongoing care suffering for it. Leave one of those out and the signature carries almost nothing.
| Disclosure standard | Reasonable practitioner | Reasonable patient |
|---|---|---|
| What it measures | What a competent peer would normally disclose | What this patient would want to know |
| Effect on your wording | Tolerates shorter, more general language | Pushes toward specific, named risks |
| Where it stands | Older test, still applied in some places | The standard many jurisdictions now apply |
Informed consent is valid only when the record shows the patient was told the nature of the procedure, its material risks, its expected benefits, the reasonable alternatives including no treatment at all, and their freedom to decline or withdraw without penalty, with a line confirming that questions were invited and answered.
How should the form describe the platelet rich plasma preparation and injection process itself?
Your patient should be able to picture the whole appointment before they sign anything. That means walking them through the draw, the spin and the injections in the order they'll happen, and naming anything that goes into the syringe beyond their own blood. Someone who consented to their own blood hasn't consented to a mixture.
- Venous draw: Roughly 18 to 55 mL of the patient's own blood, depending on system and treatment area.
- Centrifugation: The tube is spun to separate the platelet rich fraction from red cells and most plasma.
- Anything added: Calcium chloride or another activator, local anaesthetic, or any adjunct, each named.
- Scalp injections: A grid of small, shallow injections into or just beneath the dermis across the thinning area.
- Comfort and time: How discomfort is handled, and a visit length providers commonly quote as under two hours.
The procedure description must state that roughly 18 to 55 millilitres of the patient's own blood is drawn, spun in a centrifuge to concentrate the platelet rich fraction, and injected in a grid of shallow scalp injections, with any added activator, anaesthetic or adjunct named individually.
What must the form disclose about the regulatory status of platelet rich plasma for hair loss?
Clearance and approval get used as though they mean the same thing, and that mix-up is the most common defect in these documents. A cleared centrifuge means a device may be sold for preparing the plasma. It says nothing at all about whether anyone approved injecting that plasma into a thinning scalp.
- Device clearance: Covers the centrifuge, tubes and kit, sometimes for an unrelated clinical use.
- Treatment status: Off label for pattern hair loss, which is lawful and routine across medicine.
- Evidence base: Small randomised trials and case series, varying protocols, positive but inconsistent results.
- Coverage: Elective and unapproved for this use, so insurance is very unlikely to pay.
Device clearance for preparing platelet rich plasma is not approval of platelet rich plasma as a treatment for pattern hair loss, so the form must state that this use is off label, that off label use is lawful, that the evidence rests on small trials with varying protocols, and that insurance is very unlikely to cover it.
Which specific risks and complications must be named rather than covered by general language?
A general phrase about possible complications protects nobody. Your patient has to be able to picture the specific thing that might happen to them, which means the common nuisances and the rare serious events belong in separate groups rather than one blurred paragraph. A risk that could reasonably have been anticipated and was left unnamed is treated as undisclosed.
A consent form must name the expected effects individually, including injection pain, headache, pinpoint bleeding, swelling, bruising and temporary shedding, and separately name the uncommon serious ones including infection, persistent nodules, nerve or vascular injury and fainting during the blood draw, alongside the plain statement that some patients see no measurable improvement.
What alternatives to the treatment must be presented for consent to be genuinely informed?
Alternatives are what turn a signature into a decision rather than a purchase. The list has to open with doing nothing, and it has to say what doing nothing actually means here, which is steady progression rather than holding where you are today.
- No treatment: Continued gradual loss, spelled out, not a stable status quo.
- Established drug therapy: Topical minoxidil, oral finasteride or dutasteride where appropriate, each with its own risks.
- Device options: Low level laser therapy and microneedling, named with roughly what each involves.
- Surgical transplantation: A different category of intervention, since it redistributes follicles rather than improving them.
Every reasonable alternative has to be named, including doing nothing, topical minoxidil, oral finasteride or dutasteride, low level laser therapy, microneedling and surgical hair transplantation, even when the practice doesn't offer them, because informed consent is owed to the patient's decision and not to the clinic's menu.
How should realistic expectations about results and timelines be documented?
This is the section where consent forms quietly slide into advertising. Read each sentence and ask whether it would sit comfortably in an ad; if it would, it doesn't belong here. Timelines are the honest version of the same point, because a patient who expects a change in three weeks will be back in your inbox in three weeks.
The form must state that results are not guaranteed, that a proportion of patients experience no measurable change, and that a fair assessment of density takes at least three to six months judged by photographic comparison under matched lighting, with the treatment aimed at thickening miniaturising follicles rather than regrowing areas bald for years.
What financial and billing terms belong in the consent document?
Money generates more complaints in elective work than the medicine ever does. The argument you're heading off is a specific one: a patient finished the course, saw nothing, and wants the fee back. A document that already said results aren't guaranteed, and that the fee buys the service delivered rather than a result, ends that argument before it starts.
- Session and package price: What one session costs, what a package covers, whether unused sessions expire.
- Refund position: Explicit and unambiguous, stating the fee buys treatment delivered, not an outcome.
- Insurance status: Cosmetic, not expected to be covered, and any receipt isn't a claim form.
- Maintenance spend: Shown before the first payment, not raised once the initial course ends.
The financial terms must state the price of a single session and of any package, exactly how many sessions that package covers, whether unused sessions expire, the refund position in unambiguous words, that the treatment is cosmetic and not expected to be covered by insurance, and the likely cost of maintenance before the first payment is taken.
What should the form say about ongoing maintenance and what happens if treatment stops?
Call it maintenance therapy rather than a cure, because that's honestly what it is. The hormonal and genetic process driving the loss keeps running whether or not you keep injecting, so whatever you gain is held only while the stimulus continues.
The form must state that platelet rich plasma is maintenance therapy rather than a cure, that gains are expected to diminish once sessions stop because the underlying loss continues, and that durability is not well established beyond the roughly six month horizon most published studies follow.
How should consent for photographs, records, and any promotional use be handled?
A patient can want the procedure and still not want their scalp on your website. Those are two separate decisions, so they need two separate signatures. Burying the second one inside the first is the quickest way to lose an argument you should never have been in.
Photography consent must sit in its own section with its own signature and separate permissions for clinical documentation, internal teaching and external promotional use, must address identifiability directly, must state that future use can be withdrawn while images already distributed cannot always be recalled, and must confirm that refusing photography changes nothing about the treatment.
What medical history and contraindication attestations should the patient complete?
Screening is the one part of the paperwork that actually prevents harm instead of just disclosing it. Ask about medication in general terms and you'll get a clean sheet back from someone on daily aspirin and high dose fish oil, because people don't count over-the-counter products as drugs. Name each one and you find out.
- Bleeding and platelet disorders: Low platelet counts, haemophilia, any diagnosed bleeding tendency, asked by name.
- Named medications: Anticoagulants, antiplatelets, recent high dose anti-inflammatories, systemic corticosteroids, high dose fish oil.
- Malignancy: Active blood cancer treated as a contraindication; past cancer warrants its own question and a conversation.
- Defer or postpone: Active scalp or systemic infection, significant anaemia, pregnancy and breastfeeding.
The screening section must ask by name about platelet and clotting disorders, anticoagulant, antiplatelet, high dose anti-inflammatory, corticosteroid and fish oil use, active malignancy, active scalp or systemic infection, and pregnancy or breastfeeding, and must carry the patient's signed attestation that the answers are complete and accurate.
What signature, witness, and documentation requirements make the consent defensible?
Signatures are the dullest part of the document and the part most often done badly. A form dated to the same minute as the procedure invites the argument that nobody had time to consider anything, and that argument tends to land.
- Timing: Signed far enough ahead to reflect, ideally at a separate consultation, and never after sedation or a numbing agent.
- Patient signature and a real date: Written in their own hand, never pre-filled.
- The clinician who treats: The person performing the procedure signs to confirm they personally explained it.
- Witness where it earns its place: Remote signing, or any case where capacity might later be questioned.
- Chart note and retention: An independent note of what was discussed and declined, kept for the jurisdiction's full record period.
Consent is defensible when the patient signs and dates the form in their own hand before any sedation or numbing agent is applied, the clinician who will perform the procedure signs to confirm they personally explained it, a chart note independently records the discussion and the alternatives declined, and the form is retained for the full medical record period.
